Other routes, such as buccal or rectal administration, have been explored in the past, but are unlikely to play a role in clinical practice
Discuss any doubts or concerns you may have about the information presented in the patient information leaflet with your doctor
Neuropsychopharmacology 40 (8), 19691978
In patients with Hashimotos thyroiditisrelated hypothyroidism, LT4 therapy reduces oxidative stress and improves antioxidant status (Mikulska et al
GLP-1 RAs were identified in the DRUG files using generic or brand names, including exenatide (BYETTA, BYDUREON BCISE), liraglutide (VICTOZA, SAXENDA, XULTOPHY), lixisenatide (LYXUMIA, ADLYXIN, SOLIQUA), dulaglutide (TRULICITY), semaglutide (OZEMPIC, RYBELSUS, WEGOVY), and tirzepatide (MOUNJARO, ZEPBOUND)